Human iPS Cell Line (Episomal, CD34+, ApoE Knockout)
|Catalog#||Unit||Unit Price (USD)||Actions|
|iPS36||5x105 cells/vial||$2,835.00||Add to Cart|
ALSTEM’s human isogenic iPS cell lines carrying main APOE variants (APOE-ε2, cat# iPS46; APOE-ε3, cat# iPS26; APOE-ε4, cat# iPS16) and an APOE knock-out line (cat# iPS36) share the same genetic background, and are good candidates for studying AD-related pathologies in neurons induced specifically by ApoE4, as well as for drug discovery. Highlight of these lines include:
- Derived from one single iPSC clone
- Sharing the same genetic background
- Off the shelf - simple thaw the cells and plate them onto serum-free, feeder-free culture
- Transgene- and virus-free
- Demonstrated expression of pluripotency markers and endogenous alkaline phosphatase activity
ALSTEM’s footprint-free human iPS (induced pluripotent stem) cell line with APOE knockout (KO) (cat# iPS36) was derived from the Alstem's iPSC line (cat# iPS16) by advanced genome editing tool. Sequencing results confirmed that this iPS36 isogenic iPSC line has a stable 100 bp homozygous deletion in the exon 2 of APOE gene (Figure 1). The morphology of this human iPS cell line is identical to that of human ES cells. The cells also express the pluripotency markers TRA-1-60, SSEA-3 and OCT4, and demonstrate strong endogenous alkaline phosphatase activity.
|Product Name||Human iPS Cell Line (Episomal, CD34+, ApoE Knockout)|
Dry Ice - Overnight Shipping
|Storage and Stability||
Store in vapor phase of liquid nitrogen immediately upon receipt. This product is stable for 6 months when stored as directed.
Human iPS cells were grown in feeder free conditions with mTeSR1 medium. Each lot of human iPS cells is tested for growth and viability following recovery from cryopreservation. In addition, each lot is tested for expression of TRA-1-60 and Oct4, as well as the activity of alkaline phosphatase.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.